Literature DB >> 2912611

The halo skeletal fixator. Principles of application and maintenance.

M J Botte1, S R Garfin, T P Byrne, S L Woo, V L Nickel.   

Abstract

The halo skeletal fixator, originally developed for use in patients with poliomyelitis, is now widely used with many types of cervical spine instabilities. Despite its demonstrated effectiveness, certain problem areas, including pin loosening and infection, have been identified. These problems have subsequently inspired detailed studies of skull osteology, biomechanics of pin fixation, and comparisons of techniques of application. Based on these studies, specific recommendations concerning the application and maintenance of the halo have developed. Anterior pin sites should be located in the safe zone approximately 1 cm superior to the orbital rim, cephalad to the lateral two-thirds of the orbit, and below the greatest circumference of the skull. The optimal posterior pin sites are located posterolaterally, diagonal to the corresponding contralateral anterior pins. Pins should be inserted perpendicular to the skull, tightened to eight inch/pounds (0.90 Newton-meter), and retightened once at 48 hours. A subsequent loose pin may be retightened once to eight inch/pounds if resistance is met; otherwise, it should be removed and a new one placed in a different location. Infected pins require antibiotic therapy, wound care, and possibly pin-site change and wound debridement.

Entities:  

Mesh:

Year:  1989        PMID: 2912611

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

Review 1.  Role of conservative treatment of cervical spine injuries.

Authors:  Philippe Lauweryns
Journal:  Eur Spine J       Date:  2009-08-08       Impact factor: 3.134

2.  Letter: Reconsidering Bone Morphogenetic Protein in the Cervical Spine: Selective Use for Managing Type II Odontoid Fractures in the Elderly.

Authors:  Francis J Jareczek; Kingsley O Abode-Iyamah; Efrem M Cox; Nader S Dahdaleh; Patrick W Hitchon; Matthew A Howard
Journal:  Oper Neurosurg (Hagerstown)       Date:  2017-12-01       Impact factor: 2.703

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.